New SEREX Antigens, Molecular Target to Diagnosis and Treatment for Esophageal Cancer
Project/Area Number |
16390372
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Chiba University |
Principal Investigator |
OCHIAI Takenori Chiba University, GRADUATE SCHOOL OF MEDICINE, PROFESSOR, 大学院・医学研究院, 教授 (80114255)
|
Co-Investigator(Kenkyū-buntansha) |
SHIMADA Hideaki Chiba University, GRADUATE SCHOOL OF MEDICINE, ASSISTANT PROFESSO, 大学院・医学研究院, 講師 (20292691)
HIWASA Takaki Chiba University, GRADUATE SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 大学院・医学研究院, 助教授 (30260251)
TOMONAGA Takashi Chiba University, GRADUATE SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 大学院・医学研究院, 助教授 (80227644)
|
Project Period (FY) |
2004 – 2006
|
Project Status |
Completed (Fiscal Year 2006)
|
Budget Amount *help |
¥14,100,000 (Direct Cost: ¥14,100,000)
Fiscal Year 2006: ¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2005: ¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2004: ¥5,900,000 (Direct Cost: ¥5,900,000)
|
Keywords | Esophageal cancer / Squamous cell carcinoma / SEREX / tumor marker / TROP2 / GLUT-1 / SLC2A1 / Myomegalin / TRIM21 / GLUT1 / myomegalin / 食道扁平上皮癌 / SEREX抗体 |
Research Abstract |
In order to identify new serum markers of esophageal squamous cell carcinoma (SCC), we performed serological identification of antigens by recombinant cDNA expression cloning (SEREX). E.coli was infected with λZAPII phage cDNA library prepared from mRNA of an esophageal cancer cell line (T.Tn), and IPTG-induced cDNA products were screened for interaction with antibodies in allogeneic sera of patients with esophageal SCC. We identified TROP-2, GLUT-1/SLC2A1, TRIM21, myomegalin, as new SEREX antigens for esophageal SCC. Western blotting analysis revealed that serum anti-antibodies for these SEREX antigens were present in 20 to 47% of patients but not in healthy controls. Although the presence of serum SEREX-Abs were not related to any of clinicopathological features of the patients concerned, multivariate analysis indicated that presence of s-myomegalin-Abs was significantly associated with favorable prognosis. Moreover, s-TROP-2-Abs was associated with tumor size. Because there serum antibodies against SEREX antigens were not associated with other conventional tumor markers, there serum markers were useful as a new tumor markers for esophageal SCC.
|
Report
(4 results)
Research Products
(17 results)
-
[Journal Article] Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma2007
Author(s)
Shimada H., Kuboshima M., Shiratori T., Nabeya Y., Takeuchi A., Takagi H., Nomura, F., Takiguchi, M., Ochiai, T., Hiwasa, T
-
Journal Title
International Journal of Oncology 30
Pages: 97-103
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] TSerum anti-myomegalin antibodies in patients with esophageal squamous c ell carcinoma2007
Author(s)
Shimada H., Kuboshima M., Shiratori T., Nabeya Y., Takeuchi A., Takagi H., Nomura, F., Takiguchi, M., Ochiai, T.Hiwasa
-
Journal Title
International Journal of Oncology 30
Pages: 97-103
Description
「研究成果報告書概要(欧文)」より
Related Report
-
-
[Journal Article] Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma2006
Author(s)
Kuboshima, M., Shimada, H., Liu, T.L., Nomura, F., Takiguchi, M., Hiwasa, T., Ochiai, T
-
Journal Title
Cancer Science 97
Pages: 380-386
NAID
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-kappaB p65 in esophageal carcinoma cells : possible involvement of Fas/Fas-L synergism.2006
Author(s)
Liu, T.L., Shimada, H., Ochiai, T., Shiratori, T., Lin, S.E., Kitagawa, M., Harigaya, K., Maki, M., Oka, M., Abe, T., Takiguchi, M., Hiwasa, T.
-
Journal Title
Apoptosis 11
Pages: 1025-1037
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] An essential role of alternative splicing ofc-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.2006
Author(s)
Matsushita, K., Tomonaga, T., Shimada, H., Shioya, A., Higashi, M., Matsubara, H., Harigaya, K., Nomura, F., Libutti, D., Levens, D., Ochiai, T
-
Journal Title
Cancer Res 66
Pages: 1409-1417
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin.2006
Author(s)
Nishimori, T., Tomonaga, T., Matsushita, K., Oh-Ishi, M., Kodera, Y., Maeda, T., Nomura, F., Matsubara, H., Shimada, H., Ochiai
-
Journal Title
Proteomics 6
Pages: 1011-1018
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-kappaB p65 in esophageal carcinoma cells : possible involvement of Fas/Fas-L synergism.2006
Author(s)
Liu, T.L., Shimada, H., Ochiai, T., Shiratori, T., Lin, S.E., Kitagawa, M., Harigaya, K., Maid, M., Oka, M., Abe, T., Takiguchi, M., Hiwasa, T.
-
Journal Title
Apoptosis 11
Pages: 1025-1037
Description
「研究成果報告書概要(欧文)」より
Related Report
-
[Journal Article] An essential role of alternative splicing ofc-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.2006
Author(s)
Matsushita, K., Tomonaga, T., Shimada, H., Shioya, A., Higashi, M., Matsubara, H., Harigaya, K., Nomura, F., Libutti, D., Levens, D.Ochiai, T
-
Journal Title
Cancer Res 66
Pages: 1409-1417
Description
「研究成果報告書概要(欧文)」より
Related Report
-
[Journal Article] Proteomic analysis of primary esophageal squamous cell carcino ma revealsdownregulation of a cell adhesion protein, periplakin.2006
Author(s)
Nishimori, T., Tomonaga, T., Matsushita, K., Oh-Ishi, M., Kodera, Y., Maeda, T., Nomura, F., Matsubara, H., Shimada, H., Ochiai
-
Journal Title
Proteomics 6
Pages: 1011-1048
Description
「研究成果報告書概要(欧文)」より
Related Report
-
[Journal Article] Enhancement of chemosensitivity toward peplomycin by calpastatin-stabillized NF-kappaB p65 in esophageal carcinoma cells : possible involvement of Fas/Fas-L synergism.2006
Author(s)
Liu, T.L., Shimada, H., Ochiai, T., Shiratori, T., Lin, S.E., Kitagawa, M., Harigaya, K., Maki, M., Oka, M., Abe, T., Takiguchi, M., Hiwasa, T.
-
Journal Title
Apoptosis 11
Pages: 1025-1037
Related Report
-
[Journal Article] An essential role of alternative splicing of c-myc suppressor FUSE-blinding protein-interacting repressor in carcinogenesis.2006
Author(s)
Matsushita, K., Tomonaga, T., Shimada, H., Shioya, A., Higashi, M., Matsubara, H., Harigaya, K., Nomura, F., Libutti, D., Levens, D., Ochiai, T
-
Journal Title
Cancer Res 66
Pages: 1409-1417
Related Report
-
[Journal Article] An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.2006
Author(s)
Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T.
-
Journal Title
Cancer Res. 66(3)
Pages: 1409-1417
Related Report
-
[Journal Article] Proteomic analysis of primary esophageal squamous cell carcinoma reveals down regulation of a cell adhesion protein, periplakin.2006
Author(s)
Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T.
-
Journal Title
Proteomics 6(3)
Pages: 1011-1018
Related Report
-
-
-